
Oflatune-OZ Tablets by Fortune Labs are formulated with Ofloxacin and Ornidazole, a combination commonly prescribed for the treatment of bacterial and protozoal infections. This medicine is often used in cases of gastrointestinal infections, diarrhea, dysentery, and other intestinal infections where mixed infection is suspected. Ofloxacin is an antibiotic that helps fight bacteria, while Ornidazole is an antiprotozoal and antibacterial agent that supports the treatment of infection-causing organisms. Oflatune-OZ Tablets should be taken strictly as prescribed by a medical professional.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?